3 times QC before delivery.
12-month shelf life.
Strong technical support
Prompt response
After-sales service guarantee.
Our technical team will regularly release the latest study and objective testing results as well. We will also keep our partners or end-users upated of our new testing technique.
New Checkpoint Inhibitors Activating Both T and NK Cells
Cancer treatment has changed dramatically in the last decade -- immunotherapy has revolutionized cancer treatment ...[Read More]
Why it is so difficult to stop taking drugs?
In recent years, some news about stars being caught taking drugs frequently appears Knowing that taking drugs does great harm to people, why do they take drugs?...[Read More]
Hyaluronic Acid (HA)
Japanese researchers report in the online edition of the proceedings of the national academy of sciences that they have discovered a new mechanism for breaking down HA（hyaluronic acid） ...[Read More]
Production of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification
Production of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification...[Read More]
New cancer immunotherapy
Many scientists and drug researchers are developing new immunotherapies But failure has not deterred innovation, and a new combination of immunotherapies has emerged ...[Read More]
Colony Stimulating Factor 2, Granulocyte Macrophage (GMCSF)
In a new study, researchers from the Mayo clinic in the United States have developed a strategy that could improve the performance of chimeric antigen receptor (CAR) t-cell (car-t cell) therapies in treating cancer Relevant research results are recently published in the journal Blood ...[Read More]
Histone H1 (H1)
In a new study published in the international journal Nature, researchers from the university of Copenhagen have discovered new functions of the histone H1, raising awareness of how cells protect and repair DNA damage ...[Read More]
Why ELISA Kits?
With so many new products and technologies being developed and improved upon, it can be challenging to decide what products best suit your experiments ...[Read More]
Inhibition of Glutamine Metabolism Improving the Efficacy of CAR-T Cell Immunotherapy
Jeffrey Rathmell, Ph D , professor of immuno-biology at Vanderbilt university in the United States, and his colleagues have previously shown that cellular fuel glucose plays an important role in the activation and function of t-cells that promote inflammation and eliminate pathogens ...[Read More]
Developed a New Way to Block Cancer Immunosuppression
Developed a New Way to Block Cancer Immunosuppression...[Read More]
